Today, through companies like Ginkgo BioWorks, a Bayer partner, many more opportunities are arising to use synthetic biology in everything from medicine to farming to manufacturing.
Synthetic biology involves the wholesale redesign or construction of biological entities to carry out desirable biotechnological processes. It’s already revolutionized the treatment of diabetes, for example. Since 1982, insulin has been produced by inserting a human gene into a common bacterium. Today, through companies like Ginkgo BioWorks, a Bayer partner, many more opportunities are arising to use synthetic biology in everything from medicine to farming to manufacturing.